SEC24C

Protein transport protein Sec24C · P53992 · SEC24C on Sugi Atlas →

0 patent compounds predicted against SEC24C, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SEC24C by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options PHASE3COMPLETED
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers PHASE1/PHASE2RECRUITING
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops PHASE2UNKNOWN
Effects of Vitamin D Supplementation on Muscle Protein Synthesis PHASE2COMPLETED
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy PHASE2COMPLETED
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients PHASE1UNKNOWN
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Genetic, Dietary and Environmental Influences on Vitamin D Metabolism nanCOMPLETED
Effects of Vitamin D on Health Promotion During Pregnancy and Its Impact on Prematurity-Related Outcome nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health nanUNKNOWN
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment. nanACTIVE_NOT_RECRUITING
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Replacement of Vitamin D in Patients With Active Tuberculosis nanCOMPLETED
Candidate Gene for Hyperferritinemia nanUNKNOWN
Pediatric Evaluation and Registry for Liver Cholestasis in Canada nanRECRUITING
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
MEHMO Natural History and Biomarkers nanRECRUITING
Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features nanUNKNOWN
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts nanCOMPLETED
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas nanACTIVE_NOT_RECRUITING
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside nanUNKNOWN
Phenotypic and Genotypic Characterization of Subjects With Syndromic Obesity: Identifying New Candidate Genes by Exome Sequencing (OBEXOME) nanCOMPLETED
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a SEC24C binder may also engage these)

ProteinNameSimilarity
O94855 0.994 O94855 →
Q9M081 0.992 Q9M081 →
Q9M291 0.981 Q9M291 →
Q9SFU0 0.980 Q9SFU0 →
Q876F5 0.977 Q876F5 →
F1R4C4 0.976 F1R4C4 →
P40482 0.976 P40482 →
Q6CLE0 0.976 Q6CLE0 →
Q27974 0.975 Q27974 →
Q6C2T4 0.975 Q6C2T4 →
Q8VDM6 0.974 Q8VDM6 →
Q875Q0 0.974 Q875Q0 →
Q9UUI5 0.973 Q9UUI5 →
Q99LI8 0.973 Q99LI8 →
Q960X8 0.973 Q960X8 →
P38810 0.973 P38810 →
Q0V8S0 0.972 Q0V8S0 →
Q9U1H9 0.972 Q9U1H9 →
A5DPC0 0.972 A5DPC0 →
Q9USS7 0.972 Q9USS7 →
O54772 0.972 O54772 →
Q7SYD5 0.971 Q7SYD5 →
P25799 0.971 P25799 →
O75061 0.971 O75061 →
Q3UPL0 0.971 Q3UPL0 →
Q6P9Z1 0.971 Q6P9Z1 →
Q7Q2B7 0.971 Q7Q2B7 →
Q9Z2Q1 0.971 Q9Z2Q1 →
SEC23IP SEC23-interacting protein 0.971 landscape →
Q32NW2 0.971 Q32NW2 →